SCHEMBL9465535

SCHEMBL9465535

O=c1[nH]nc(-c2ccccc2)nc1Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 3/20 0.61
▸ NR1H3 Q13133 2/20 0.61
▸ PARP1 P09874 4/20 0.55
▸ AR P10275 1/20 0.55
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ DAO P14920 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.47
▸ LMNA P02545 2/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ PRMT5 O14744 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9465025 0.86 NR1H2 (0.48) NR1H2NR1H3PARP1ARPOLB
SCHEMBL9464798 0.86 ALDH1A1 (0.49) NR1H2NR1H3PARP1ARNPC1
SCHEMBL1528283 0.76 NR1H2 (1.00) NR1H2NR1H3NPC1RAB9APOLB
SCHEMBL10743236 0.73 PARP1 (0.63) PARP1ARALDH1A1HPGDCYP2C9
SCHEMBL9465143 0.73 NR1H2 (0.53) NR1H2NR1H3NPC1RAB9APOLB
SCHEMBL863462 0.71 AR (1.00) PARP1ARCYP2C9LMNAPRMT5
SCHEMBL7874800 0.69 HPGD (0.75) PARP1ARALDH1A1HPGDCYP2C9
SCHEMBL9464804 0.69 NR1H2 (0.49) NR1H2NR1H3NPC1RAB9APOLB
SCHEMBL11706631 0.69 PARP1 (0.53) NR1H2NR1H3PARP1ARALDH1A1
SCHEMBL1752918 0.68 MAPT (0.68) PARP1ARRAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5254548-A Treating dysfunction of cholinergic system ADIR ET COMPAGNIE (FR) 1993-10-19 — — US disclosed
Send feedback